secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROCEPT BioRobotics Corp (PRCT)
CIK:        0001588978
Form:       8-K
Filed at:   2023-11-01T23:59:59+00:00
Accession:  0001588978-23-000025
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PROCEPT BioRobotics Q3 revenue $35.1M (+72% YoY); raises FY2023 guidance to $133.5M
--------------------------------------------------------------------------------

- Revenue $35.1M, up 72% YoY; U.S. handpiece/consumables $17.0M, up 113%.
- Sold 38 U.S. robotic systems in Q3; install base 271; system revenue $13.5M, +37%.
- Gross margin 54% vs 50% prior year; net loss $24.6M vs $22.6M.
- FY2023 revenue guidance raised to $133.5M (78% growth) from $131.0M; Adj. EBITDA loss guided to ($76.9M).
- Completed $162M equity follow-on; received FDA IDE for Aquablation prostate cancer trial.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1588978/000158897823000025/0001588978-23-000025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1588978/000158897823000025/prct-20231101.htm
  HTML page:      https://secwatch.observer/filing/0001588978-23-000025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer